APA (7th ed.) Citation

SL, S., AM, W., MJ, M., MH, J., & W, D. (2025). Reactive granulomatous dermatitis arising in the setting of interleukin-17 inhibition successfully treated with tofacitinib. JAAD case reports, 69, 194. https://doi.org/10.1016/j.jdcr.2025.09.043

Chicago Style (17th ed.) Citation

SL, Spaulding, Wride AM, Murphy MJ, Junejo MH, and Damsky W. "Reactive Granulomatous Dermatitis Arising in the Setting of Interleukin-17 Inhibition Successfully Treated with Tofacitinib." JAAD Case Reports 69 (2025): 194. https://doi.org/10.1016/j.jdcr.2025.09.043.

MLA (9th ed.) Citation

SL, Spaulding, et al. "Reactive Granulomatous Dermatitis Arising in the Setting of Interleukin-17 Inhibition Successfully Treated with Tofacitinib." JAAD Case Reports, vol. 69, 2025, p. 194, https://doi.org/10.1016/j.jdcr.2025.09.043.